À propos
Matthew Spencer is a Partner at Boult Wade Tennant and a Chartered UK Patent Attorney and European Patent Attorney who heads the firm's Cambridge Biotechnology and Life Sciences Group. He advises biotech and pharmaceutical clients on patent prosecution and strategic portfolio development (particularly immunotherapy), freedom-to-operate analysis, and contentious EPO opposition and appeal proceedings including coordination with national litigation and UPC-related strategy.
Domaines d’expertise
Intellectual PropertyPatentsBiotechnologyLife SciencesPharmaceuticalsPatent Litigation
Bureau
Expertise
ImmunotherapyBiotechnologyPharmaceuticalsPatent ProsecutionEPO Opposition and AppealFreedom-to-Operate (FTO) analysisPortfolio development
Formation
- MA (Cantab) Natural Sciences, University of Cambridge
- MSci Biochemistry, University of Cambridge
Inscriptions au barreau
- Chartered UK Patent Attorney (Chartered Institute of Patent Attorneys drafting prize noted in source)
- European Patent Attorney